AU2014206219B2 - Antimicrobial Currency, Material and Method - Google Patents

Antimicrobial Currency, Material and Method Download PDF

Info

Publication number
AU2014206219B2
AU2014206219B2 AU2014206219A AU2014206219A AU2014206219B2 AU 2014206219 B2 AU2014206219 B2 AU 2014206219B2 AU 2014206219 A AU2014206219 A AU 2014206219A AU 2014206219 A AU2014206219 A AU 2014206219A AU 2014206219 B2 AU2014206219 B2 AU 2014206219B2
Authority
AU
Australia
Prior art keywords
antimicrobial agent
currency
ppm
zinc
planar material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014206219A
Other versions
AU2014206219A1 (en
Inventor
Anders Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microban Products Co
Original Assignee
Microban Products Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007346702A external-priority patent/AU2007346702A1/en
Application filed by Microban Products Co filed Critical Microban Products Co
Priority to AU2014206219A priority Critical patent/AU2014206219B2/en
Publication of AU2014206219A1 publication Critical patent/AU2014206219A1/en
Application granted granted Critical
Publication of AU2014206219B2 publication Critical patent/AU2014206219B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Abstract A material for use in currency comprises an antimicrobial polymer material which can be used in the manufacture of banknotes having security features therein. The material can be a sheet or substrate and/or an acrylate polymer coat applied to at least one surface of the material used in the banknotes manufacture.

Description

ANTIMICROBIAL CURRENCY, MATERIAL AND METHOD
BACKGROUND OF THE INVENTION
[0001] Field of the Invention [0002] The present invention relates to a material for use in currency and currency made therefrom. More particularly, the invention includes an antimicrobial polymer material which can be used in the manufacture of banknotes having security features therein.
[0003] Prior Art [0004] Banknotes historically have been constructed of a paper or a paperlike fabric. Currency paper in the United States, for example, is composed of 25% linen and 75% cotton. Presently, some countries are experimenting with a “paper” banknote made in whole or in part of one or more polymers. Australia, Mexico, Brazil, Indonesia and China are among the nations testing or rolling out polymer-based banknotes.
[0005] Over the course of a banknote’s life, it is handled by countless individuals. In addition to handling, banknotes are routinely placed in pockets, purses, wallets, socks and other containers/locations where microbes can be found and can grow.
[0006] The likelihood of a banknote becoming contaminated with microbes is very high, as confirmed by culturing and plating of used banknotes. Bacteria can readily colonize on fiber-based and even polymer banknotes, facilitating cross-contamination and the spread of infections and/or diseases. Even were the banknote constructed wholly of one or more conventional polymers on which microbes do not traditionally flourish, such microbes certainly could survive thereon and be transmitted from one person to the next.
[0007] Banknotes typically include a number of security features to prevent counterfeiting. Specialized fibers may be interwoven into the fabric of the banknote. Red and blue fibers have long been an ingredient of U.S. paper currency. Special features such as these fibers are embedded in currency paper to ensure that reproduction is difficult. While some counterfeiters attempt to draw these fibers onto the surface of the bill, close inspection reveals the absence of the authentic embedded fiber and the clear presence of crude lines drawn on the surface. Prior to approximately 1941, such anti-counterfeit fibers were silk. Presently, red and blue synthetic fibers of various lengths are distributed evenly throughout the paper.
[0008] Security threads are useful anti-counterfeiting features and now run the width of U.S. paper currency. In some early versions of U.S. paper currency, thin security threads were added to paper. In these currencies, the number of threads in the paper represented a specific denomination.
Continuing with example of U.S paper currency, the thread for the modern $100 bill bears the phrase "USA 100". This thread print also can only be seen with transmitted light, which makes photocopy-based counterfeiting impossible.
[0009] In addition, new U.S, security threads glow red when held over ultraviolet light. Other printed features can include inks comprising metallic flakes or particles, holographic images, and the like. These features give the printed element a visual aspect that cannot readily he xerographicaliy or otherwise reproduced, [0010] Banknotes also may have a watermark added thereto. A watermark is created during the paper banknote making process and is caused by variations in the density of the paper. As light passes through the tiny variations in thickness, different Sight tones are observed. These varying tones form a clear image when held up to transmitted light.
[0011a] One key requirement of an antimicrobial or bactericidal banknote is the antimicrobial additive must not materially affect key properties of the banknotes, such as durability or one or more of the security measures as discussed above.
[0011 b] Reference to cited material or information contained in the text should not be understood as a concession that the material or information was part of the common general knowledge or was known in Australia or any other country.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] As used herein, the terms “microbe” or “microbial8' should be interpreted to encompass any of the microscopic organisms commonly studied by microbiologists. Such organisms include, but are not limited to, bacteria and fungi as well as other single-celled organisms such as mold, mildew and algae. Viral particles and other infectious agents are also Included in the term microbe.
[0.013] The term “antimicrob.iar includes biosfaiic activity, i.e.s where the proliferation of microbiological species is reduced or eliminated, and true biocidal activity where microbiological species are killed. For ease of discussion, this detailed description may make reference to bacteria and antibacterial agents. This method of presentation should not be interpreted as limiting the scope of the invention in any way.
[0014a] The term efficacy, as used herein, .is defined as the characteristic of inhibiting the growth of a microbe on a substrate, in the broadest sense, an antimicrobial banknote has bactericidal ("kill”) efficacy, which helps to counteract the public health concern of bacterial transfer from one handler of the banknote to the next.
[0014b] Throughout the specification, unless the context requires otherwise, the word “comprise” or variations such as ''comprises’1 or “comprisingVwili be understood to imply the inclusion of a stated integer or group of integers but not the .exclusion of any other integer or group of integers.
[0015] in a first embodiment, a sheet or planar substrate materia! is comprised of a polymer, such as a polypropylene film.
[0010] A banknote manufactured using a polymeric planar material, with or without an antimicrobial agent disposed therein, may alternatively or additionally bear one or more layers of a superficial polymer affixed thereto or disposed thereon. That is, a bank note can be manufactured of the antimicrobial planar materia! described above and one or more acrylate coating layers applied thereto, alternatively, a bank note made of a “pure” polymeric planar material can be affixed thereto or disposed thereon an acrylate layer, the acrylate polymer layer containing one or more antimicrobial agents.
[0017] The superficial polymeric layer or coating can be a transparent acrylate polymer layer or coating. This superficial polymer layer/coating can be applied to protect the printing and the note itself. The methods for applying such coatings are known to those of skill in the bank note manufacturing art.
[0018] Two thin layers generally can applied on each side of the banknote, for a total thickness of perhaps 6 microns per note. Greater or lesser total thicknesses can be employed as desired by the bank note producer without departing from the inventive concept disclosed herein.
[0019] The acrylate superficial polymer coating composition may be cured in a variety of methods, including via an ultraviolet radiation curing process. The UV curing process is especially attractive, as more rapid curing of the coating material permits higher-speed banknote production lines. However, many antimicrobial agents are known to be susceptible to degradation upon exposure to ultraviolet radiation.
[0020] It should be noted that susceptibility of the antimicrobial agent to ultraviolet irradiation can be present regardless of the placement of the agent(s) in the polymeric planar material, the acrylate coating composition, or both.
[0021] Effective antimicrobial agents can be incorporated into the planar polymeric material, the acrylate coating composition, or both. Suitable agents include silver, copper or zinc in various forms, such as in zeolite or amorphous glass powder. Silver, for example, alternatively may be utilized in ionic or elemental form or in sol/gel form; the general concept being that the inorganic antimbrobia! be disposed in the currency material in an ion exchangeable form. In some cases, it may be desirable to add a dispersing agent with the antimicrobial agent to prevent agglomeration of the antimicrobial agent in the currency materia!.
In one form of the invention, there is provided a currency, comprising: a pianar material having at least a first surface; a first antimicrobial agent disposed In a polymer comprising the pianar material; an acrylate polymer coating affixed to the at least first surface of the planar material; and a second antimicrobial agent disposed in the acrylate· polymer coating affixed to the at least first surface of the pianar materia); and wherein the first microbial agent is different from the second antimicrobial agent.
In one form of the invention, there is provided a method for manufacturing a currency, comprising: providing a planar material at least partly composed of a polymer and having at least a first surface, the polymer having a first antimicrobial agent disposed therein; applying an acrylate coating composition to the at least first surface of the planar material, the acrylate coating composition containing a second antimicrobial agent; and polymerizing the acrylate coating composition to form an acrylate coating layer on the at least first surface of the planar material; wherein the first antimicrobial agent is different from the second antimicrobial agent.
[0022} Surprisingly, 2,4,4'-tnchloro-2!-hydrQxydiphenyl ether, which is a diphenyl ether (bis-phenyi) derivative, has proven to be an effective antimicrobial additive. Triclosan is widely known to be sensitive to ultraviolet radiation, and it was not expected that it would be suitable for use in a UV curing process.
[0023] Similarly, isothiazolone-based compounds selected from the group consisting of 1,2-benzisothiazoline-3-one (CAS No. 2634-33-5): N-bufyM,2-benzisothiazolin-3-one (CAS No. 4299-07-4); 2-octyl-isothiazoione (CAS No. 26530-20-1); 4,5-dichioro~2-N-octy!-3(2H)-isothiazoione (CAS No. 84359-81-5); methyI-3(2hl)-isothIazolone (CAS No. 2682-20-4); and chioro-2-methyl-3(2H)-isothiazolone (CAS No. 26172-55-4) have been found to be efficacious antimicrobiai agents. f0024] Additional antimicrobial agents suitable for use further include diiodemethyi p-tolyJsulfone; zinc and sodium pyrithiones; azoles (such as propiconazoles), poiyhexamethyiene biguanide hydrochloride (PMBH); 3,4,4-tnchbrocarbaniiide; photocatalytic titanium dioxide, and barium inelaborate monohydrate (i.e., CAS No. 13701-59-2).
QUANTITATIVE EVALUATION OF ANTIBACTERIAL ACTIVITY
[0025] For the testing, a protocol was selected which measured the percent kill in a bacterial population over a period of time when put in contact with banknote samples.
[0026] Tests were conducted against two common bacteria: the grampositive Staphylococcus aureus, which is found almost everywhere in and on the body, and which can cause numerous infections; as well as the gramnegative Escherichia coli, which is a common “bathroom bacteria” that can cause severe food poisoning. With good results against these organisms, efficacy against a broad spectrum of other bacteria can be predicted.
[0027] Ten samples marked Secu-GB1 -A-260503, Secu-GB2-A-260503, Secu-GB3-A-260503, Secu-GB4-A-260503, Secu-GB5-A-260503, Secu-C-A-260503, Secu-C-B-260503, Secu-C-C-260503, Secu-C-D-260503 and Secu-C-E-260503 were manufactured employing 2,4,4'-trichloro-2'-hydroxydiphenyl ether in the acrylate composition applied as a coating layer on the planar material.
[0028] Samples from the bank note prototypes were evaluated for their antibacterial activity in accordance with the modified method AATCC 100-1993. The tests were performed against the organisms Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 8739.
Table 1 _Staphylococcus aureus_
Table 2 _Escherichia coli
Notes: Counts per test are means of replicates G. Mean = Geometric Mean (Log mean) [0029] The products were found to have significant biocidal properties over the 24 hour period under the above test conditions.
KEY TO ANTIMICROBIAL ADDITIVE FORMULATIONS
[0030] There were 3 groups of as samples as shown below. Tables 3 and 4 were triclosan-treated samples. As can be seen, the samples were made in duplicates but were labeled differently; for example, GB1 in Table 3 had the same percentage of triclosan as sample E in Table 4. _Table 3_
Table 4: Treated Blind Samples
[0031] The control sample containing no antimicrobial additive predictably had no ability to kill bacteria; instead, the number of bacteria actually increased over the assay period. However, all other test samples containing various concentrations of antimicrobial additive displayed strong bactericidal efficacy, in most cases more than 99% kill.
[0032] From the strong log reductions observed even at 625 ppm 2,4,4'-trichloro-2'-hydroxydiphenyl ether, it is reasonably expected that the antimicrobial agents disclosed herein may be used with efficacy at concentrations ranging from about 500 ppm to about 20,000 ppm.
[0033] In another embodiment of the currency, two or more antimicrobial agents can be combined in the article. In one instance, a first antimicrobial agent can be incorporated in the planar material and a second antimicrobial agent in the acrylate coating layer (by way of disposal in the acrylate coating composition to be applied to at least a first surface of the planar material). Alternatively, the multiple antimicrobial agents may together be disposed in either of the planar material or the acrylate coating composition/layer.
[0034] Use of two or more antimicrobial agents permits the selection of antimicrobial agents having specific activities, for example against different microbes or with varying rates of antimicrobial efficacy.
[0035] It will therefore be readily understood by those persons skilled in the art that the present composition and methods are susceptible of broad utility and application. Many embodiments and adaptations other than those herein described, as well as many variations, modifications and equivalent arrangements, will be apparent from or reasonably suggested to one of ordinary skill by the present disclosure and the foregoing description thereof, without departing from the substance or scope thereof.
[0036] Accordingly, while the present composition and methods have been described herein in detail in relation to its preferred embodiment, it is to be understood that this disclosure is only illustrative and exemplary and is made merely for purposes of providing a full and enabling disclosure. The foregoing disclosure is not intended or to be construed to limit or otherwise to exclude any such other embodiments, adaptations, variations, modifications and equivalent arrangements.
Each document, reference, patent application or patent cited in the this text is expressly incorporated herein in their entirely by reference, which means that it should be read and considered by the reader as part of this text. That the document, reference, patent application, or patent cited in this text is not repeated in this text is merely for reasons of conciseness.

Claims (16)

  1. CLAIMS What is claimed is;
    1. A currency, comprising: a planar material having at least a first surface; a first antimicrobial agent disposed in a polymer comprising the planar material; an acrylate polymeric coating affixed to the at least first surface of the planar material; and a second antimicrobial agent disposed in the acrylate polymer coating affixed to the at least first surface of the planar material; and wherein the first antimicrobial agent is different from the second antimicrobial agent,
  2. 2. The currency according to claim 1 wherein the first antimicrobial agent is an inorganic antimicrobial agent.
  3. 3. The currency of claim 2 wherein the first antimicrobial agent is one of stiver zeolite; silver in amorphous glass; silver sol/gel; copper zeolite; copper in amorphous glass; copper sol/gel; zinc zeolite; zinc in amorphous glass; or zinc sol/gel.
  4. 4. The currency of claim 2 wherein the first antimicrobial agent is one of zinc pyrithione:; sodium pyrithione; photocatalytic titanium dioxide; or barium metaborate monohydrate.
  5. 5. The currency according to claim 1 wherein the first antimicrobial agent is an organic antimicrobial agent
  6. 6. The currency of claim 5 wherein the first antimicrobial agent is one of 2,4,4’-trichloro-2’-hydroxydiphenyl ether; diidomethyl p-tolyisulfone; an azole such as propiconazoie; polyhexamethyiene biguanide hydrochloride; or 3,4,4’- trich to rocarba n i I id e.
  7. 7, The currency of daim 5 wherein the first antimicrobial agent is an. isothiazolone-based compound such as 1 :2-benzi5othiazolin-3-one. N-hutyM ^-benzisothiazoiin-S-one, 2-ociyi-isothiazoione, 4!5-dichioro-2"N-ociyl--3(2H)- isothiazofone, meihyl-3(2H}~ isothiazoSone, or chioro-2-methy!-3(2H)-isothiazo!one.
    3. The currency of claim 1 wherein the first antimicrobial agent has a concentration in the range of from about 500 ppm to about 20,000 ppm.
  8. 9. The currency of claim 1 wherein the first antimicrobial agent has a concentration in the range of from about 5oo ppm to about 10,000 ppm and the second antimicrobial agent has a concentration in the range of from about 500 ppm to about 10,000 ppm.
  9. 10. A method for manufacturing a currency, comprising' providing a planar material at least partly composed of a polymer and having a least a first surface, the polymer having a first antimicrobial agent disposed therein; applying an acrylate coating composition to the at least first surface of the planar material, the acrylate coating composition containing a second antimicrobial agent; and polymerizing the acrylate coating composition to form an acrylate coating layer on the at least first surface of the planar material; wherein the first antimicrobial agent is different from the second antimicrobial agent.
  10. 11.. The method of daim 10 wherein the first antimicrobial agent is an inorganic antimicrobial agent.
  11. 12. The method of claim 11 wherein the first antimicrobial agent is one of silver zeolite; silver in amorphous glass; silver sol/gei; copper zeolite; copper in amorphous glass; copper sol/gei; zinc zeolite; zinc in amorphous glass; or zinc sol/gel.
  12. 13. The method of claim 11 wherein the first antimicrobial agent is one of zinc pyrithione; sodium pyrithione; photocatalytic titanium dioxide; or barium metaborate monohydrate.
  13. 14, The method of claim 10 wherein the first antimicrobial agent is an organic antimicrobial agent
  14. 15, The currency of claim 14 wherein the first antimicrobia! agent is one of 2,4,4’-trichioro-2'-hydroxydiphenyi ether; diiodemethyl p-tolylsulfone; an azole such as propiconazoie; polyhexaraethyiene biguanide hydrochloride; or 3,4,4’trichlorocarbaniiide.
  15. 16, The currency of claim 14 wherein the first antimicrobial agent is an isothiazolone-based compound such as 1,2-ben2!sothiazolin-3-one, N-butiy-1,2-benzisothiazo!in-3-one, 2-octyi-isothiazolone, 4,5-d!Ghloro-2~N-octyl-3(2H)“isothiazolone, rnethy 1-3(2H)-isothiazoione,. or chioro-2-niethy!-3(2H)'iscthiazoione.
  16. 17, The currency of claim 10 wherein the first antimicrobial agent has a concentration in the range of from about 500 ppm to about 20,000 ppm.
AU2014206219A 2007-02-09 2014-07-28 Antimicrobial Currency, Material and Method Active AU2014206219B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014206219A AU2014206219B2 (en) 2007-02-09 2014-07-28 Antimicrobial Currency, Material and Method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007346702A AU2007346702A1 (en) 2007-02-09 2007-02-09 Antimicrobial currency, material and method
AU2007346702 2007-02-09
AU2014206219A AU2014206219B2 (en) 2007-02-09 2014-07-28 Antimicrobial Currency, Material and Method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2007346702A Division AU2007346702A1 (en) 2007-02-09 2007-02-09 Antimicrobial currency, material and method

Publications (2)

Publication Number Publication Date
AU2014206219A1 AU2014206219A1 (en) 2014-08-21
AU2014206219B2 true AU2014206219B2 (en) 2016-09-15

Family

ID=51402265

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014206219A Active AU2014206219B2 (en) 2007-02-09 2014-07-28 Antimicrobial Currency, Material and Method

Country Status (1)

Country Link
AU (1) AU2014206219B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249880A1 (en) * 2004-05-07 2005-11-10 Wallace Angela I Low VOC antimicrobial coating compositions
US20060147502A1 (en) * 2004-12-30 2006-07-06 Kimberly-Clark Worldwide, Inc. Methods for controlling microbial pathogens on currency and mail

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249880A1 (en) * 2004-05-07 2005-11-10 Wallace Angela I Low VOC antimicrobial coating compositions
US20060147502A1 (en) * 2004-12-30 2006-07-06 Kimberly-Clark Worldwide, Inc. Methods for controlling microbial pathogens on currency and mail

Also Published As

Publication number Publication date
AU2014206219A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
US8592045B2 (en) Antimicrobial currency, material and method
Tayel et al. Antibacterial action of zinc oxide nanoparticles against foodborne pathogens
Egger et al. Antimicrobial properties of a novel silver-silica nanocomposite material
Kalia Biotechnological applications of quorum sensing inhibitors
Agarwala et al. Highly effective antibiofilm coating of silver–polymer nanocomposite on polymeric medical devices deposited by one step plasma process
CA2481443C (en) Data medium having biocidal properties and method for making same
JP5647672B2 (en) Information medium having antiviral properties and method for making the same
Stojak et al. Morphological responses of Legionella pneumophila biofilm to nanoparticle exposure
Chadeau et al. Evaluation of antimicrobial activity of a polyhexamethylene biguanide‐coated textile by monitoring both bacterial growth (iso 20743/2005 standard) and viability (live/dead baclight kit)
EP2634309B1 (en) Security paper
De Leersnyder et al. Influence of growth media components on the antibacterial effect of silver ions on Bacillus subtilis in a liquid growth medium
AU2020409592A1 (en) Protective varnish, in particular for security documents
Badica et al. Antibacterial composite coatings of MgB2 powders embedded in PVP matrix
AU2014206219B2 (en) Antimicrobial Currency, Material and Method
Paosen et al. Prevention of nosocomial transmission and biofilm formation on novel biocompatible antimicrobial gloves impregnated with biosynthesized silver nanoparticles synthesized using Eucalyptus citriodora leaf extract
CN106318189B (en) Antibacterial coating for negotiable securities
Pérez‐Tanoira et al. Bacterial adhesion on biomedical surfaces covered by micrometric silver Islands
Toolabia et al. Investigating toxicity and antibacterial aspects of nano ZnO, TiO2 and CuO with four bacterial species
Liyanage et al. Antimicrobials for protective clothing
Soe et al. Effect of combinations of antibiotics and gallates on biofilm formation in Staphylococcus aureus
Bal et al. Alternative pathogen control chemistry of glass fiber-reinforced polyester panels for cooling towers
Besinis Corrigendum to “Manufacturing silver nano-coating currencies to prevent the bacteria growing on the surface of currency”[Gene Rep. Volume 19, June 2020, 100648]
Subramaniyan et al. Phytolectin conjugated positively charged fatty acid amide impairs virulence factors and inhibits cross‐kingdom biofilm formation of Candida albicans and uropathogenic Escherichia coli
Yazdıç et al. Antibacterial activity of novel synthesized chitosan‐graft‐poly (N‐tertiary butylacrylamide)/neodymium composites for biomedical application
Wasa Measuring the effects of a novel titania (TiO₂) coating on microbial survival, adaptation and ecology.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)